Allelic Imbalances of the egfr Gene as Key Events in Breast Cancer Progression - the Concept of Committed Progenitor Cells

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|8|5|431-445

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.8, Iss.5, 2008-08, pp. : 431-445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy

By  

Current Pharmaceutical Design, Vol. 22, Iss. 16, 2016-05 ,pp. : 2358-2388

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging EGFR antagonists for breast cancer

By Lluch Ana   Eroles Pilar   Perez-Fidalgo Jose-Alejandro  

Expert Opinion on Emerging Drugs, Vol. 19, Iss. 2, 2014-06 ,pp. : 165-181

Informa Healthcare

Access to resources Recommend Favorite

Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients

By Payne Rachel E   Yagüüe Ernesto   Slade Martin J   Apostolopoulos Christos   Jiao Long R   Ward Becky   Coombes R Charles   Stebbing Justin  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 51-57

Future Medicine

Access to resources Recommend Favorite

Regulation of Gene Expression by Progesterone in Cancer Cells: Effects on Cyclin D1, EGFR and VEGF

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 5, 2013-04 ,pp. : 635-642

Bentham Science Publishers

Access to resources Recommend Favorite

Prostatic Tumor Stroma: A Key Player in Cancer Progression

By  

Current Cancer Drug Targets, Vol. 8, Iss. 6, 2008-09 ,pp. : 490-497

Bentham Science Publishers

Access to resources Recommend Favorite